BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37461019)

  • 21. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
    Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
    Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
    Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
    Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis.
    Liu C; Jiang F; Zhang X; Xu X
    Cancer Manag Res; 2020; 12():2777-2788. PubMed ID: 32425595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
    Rasoolnezhad M; Safaralizadeh R; Hosseinpour Feizi MA; Banan-Khojasteh SM; Roshani Asl E; Lotfinejad P; Baradaran B
    Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
    Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1.
    Zhao Y; Jin LJ; Zhang XY
    Aging (Albany NY); 2021 Jul; 13(14):18498-18514. PubMed ID: 34292880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b.
    Wei X; Tao S; Mao H; Zhu H; Mao L; Pei W; Shi X; Shi Y; Zhang S; Wu Y; Wei K; Wang J; Pang S; Wang W; Chen C; Yang Q
    Gene; 2023 Apr; 860():147230. PubMed ID: 36717039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
    Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast Cancer Stem Cell-Derived ANXA6-Containing Exosomes Sustain Paclitaxel Resistance and Cancer Aggressiveness in Breast Cancer.
    Guo Z; Guo A; Zhou C
    Front Cell Dev Biol; 2021; 9():718721. PubMed ID: 34676207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8.
    Li J; Zhu T; Weng Y; Cheng F; Sun Q; Yang K; Su Z; Ma H
    Thorac Cancer; 2022 May; 13(9):1381-1390. PubMed ID: 35396925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway.
    Chen C; Liu Y; Liu L; Si C; Xu Y; Wu X; Wang C; Sun Z; Kang Q
    J Exp Clin Cancer Res; 2023 Feb; 42(1):46. PubMed ID: 36793126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircRNA circBACH1 (hsa_circ_0061395) serves as a miR-656-3p sponge to facilitate hepatocellular carcinoma progression through increasing SERBP1 expression.
    Li G; Du P; He J; Li Y
    Biochem Biophys Res Commun; 2021 Jun; 556():1-8. PubMed ID: 33831787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
    Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S
    Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. circRNA RPPH1 Facilitates the Aggravation of Breast Cancer Development by Regulating miR-542-3p/ARHGAP1 Pathway.
    Qi L; Sun B; Yang B; Lu S
    Cancer Biother Radiopharm; 2022 Oct; 37(8):708-719. PubMed ID: 34402683
    [No Abstract]   [Full Text] [Related]  

  • 38. eIF4A3-induced circWAC promotes breast cancer progression through mediating miR-599/E2F3 axis.
    Huang WH; Yang Q; Zhang C
    Kaohsiung J Med Sci; 2022 Apr; 38(4):321-335. PubMed ID: 34989110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286.
    Ni J; Xi X; Xiao S; Xiao X
    Cancer Manag Res; 2021; 13():5573-5585. PubMed ID: 34285578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
    Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
    J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.